Abbott Gets a Brass Ring
Executive Summary
Chiron Corp. has licensed rights to HCV nucleic acid diagnostics to Abbott Laboratories on a semi-exclusive basis for use in clinical applications, excluding blood banking. HCV is one of the most coveted diagnostics tests and Chiron, which holds the patent on has been very cautious about licensing rights; so far, it has licensed immunoassay rights to two companies, two for blood banking only, and nucleic acid rights to Bayer AG. l
You may also be interested in...
Safe Blood At Any Cost?
With AIDS and HCV under control, companies large and small are looking to protect the blood supply from a range of known and as yet unknown pathogens, which pose potential threats. Near-term attention is focusing on emerging pathogen inactivation technologies, which are moving closer to the clinic, even as questions linger about their cost effectiveness and toxicity.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.